24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publication dates

Lymphoma Industry, January 2015 Market Reports from Top Publishers

You might be interested in: flow cytometry, hematology, therapeutics, cancer, melanoma, medical equipment, leukemia, t-cell lymphoma, nuclear medicine, pap smear, breast cancer, prostate cancer, atherosclerosis, colorectal cancer, pancreatic cancer.


 
1-10 of about 100 reports for Lymphoma

Lymphoma Drug Pathway Analyzer 2015

Lymphoma Drug Pathway Analyzer 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

... Before. Its capabilities moves you beyond powerful competitive intelligence to an opportunity seeking tool which lets you, by means of both present and emerging scientific knowledge, analyze the lymphoma ...

EpiZyme, Inc. (EPZM) - Financial and Strategic SWOT Analysis Review

EpiZyme, Inc. (EPZM) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Modifying enzymes, and others. The company partners with celgene, glaxosmithkline, eisai, the leukemia & lymphoma society and multiple myeloma research foundation. Epizyme is headquartered in cambridge, massachusetts ...

Biological Therapies for Cancer: Technologies and Global Markets

Biological Therapies for Cancer: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • January 2015
  • by BCC Research

... Kidney cancerleukemialymphomaliver cancermelanomamultiple myelomabrain cancerovarian cancerpancreatic cancerprostate cancerstomach cancerhead and neck cancers ...

Lymphoma Drug Pipeline Update 2015

Lymphoma Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

... In 694 developmental projects in cancer. In addition, there are 3 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 140 drugs. lymphoma drug pipeline update ...

Ceritinib  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Ceritinib - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • January 2015
  • by Ark Patent Intelligence

... This report covers:international nonproprietary name: ceritinibindications: treatment of anaplastic lymphoma kinase-positive metastatic non-small cell lung cancer which has progressed ...

Acute Lymphoblastic Lymphoma - Pipeline Review, H2 2014

Acute Lymphoblastic Lymphoma - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

... Projects- coverage of the acute lymphoblastic lymphoma pipeline on the basis of target, moa, route of administration and molecule type- latest news and deals relating related to pipeline products ...

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H2 2014

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

... Large cell lymphoma (alcl)- the report reviews key pipeline products under drug profile section which includes, product description, moa and r&d brief, licensing and collaboration details & other ...

Lymphoma Treatment Drugs Markets in China

Lymphoma Treatment Drugs Markets in China

  • $ 4 000
  • Industry report
  • December 2014
  • by Asia Market Information & Development Company

... lymphoma treatment drugs markets in china china's demand for lymphoma treatment drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow ...

Janssen-Cilag SpA SWOT Analysis, Strategy, Revenues and Profits

Janssen-Cilag SpA SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Pulmonary fibrosis (ipf) and sarcoidosis. The company develops drugs for breast and ovary cancer, prostate cancer, the lymphomas and acute myeloid leukemia. It operates a subsidiary of johnson and johnson ...

The Leukemia & Lymphoma Society, Inc. - Strategic SWOT Analysis Review

The Leukemia & Lymphoma Society, Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Key elements such as swot analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs. The leukemia & lymphoma society, inc. - Strategic swot ...

About 1 400 reports for Lymphoma

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • April 2014
    28 pages
  • Cancer  

  • United States  

    North America  

View report >

23 Companies for Lymphoma

Read our Company Profiles

Celgene Corp.

United States

Novartis Inc.

Switzerland

Seattle Genetics Inc.

United States

Pharmacyclics Inc.

United States

Bristol-Myers Squibb Co.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.